Related Experiment Video

Updated: Jun 5, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

994

Reply to: Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series

Luciano Foggia1, Luca Potestio1, Cataldo Patruno2

  • 1Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

International Journal of Dermatology
|December 4, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Upadacitinibatopic dermatitispsoriasiform atopic dermatitispsoriasistreatment

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K
Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

753

Related Experiment Videos

Last Updated: Jun 5, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

994
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K
Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

753

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

112
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
112

Articles linked to this work by shared authors, journal, and citation graph.

Upadacitinib for the Management of Atopic Dermatitis in Patients Aged ≥60 Years: A Long-Term Multicenter Real-World Study.

Dermatitis : contact, atopic, occupational, drug·2026

Current Challenges in Atopic Dermatitis: An Italian Delphi Consensus with a Special Focus on Moderate Disease.

Dermatology and therapy·2026

Contact Allergy to Textile Dye Mix in Italy: A SIDAPA Multicentre Observational Study.

Contact dermatitis·2026

Cumulative Disease Control with Upadacitinib in Moderate-to-Severe Atopic Dermatitis-A 52-Week Multicenter Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).

Dermatology and therapy·2026

Clinical Characteristics of Patients Presenting with Moderate-to-Severe Atopic Dermatitis and Concomitant Inflammatory Bowel Diseases: a Multicenter Retrospective Study.

Dermatology practical & conceptual·2026

D-CARE (Delgocitinib-Chronic hAnd Eczema Response Evaluation): A Retrospective, Multicenter, Real-World Study of Patients with Chronic Hand Eczema (CHE) Treated with Delgocitinib 2% Cream-Temporal Analysis of Symptom and Clinical Sign Response.

Dermatology and therapy·2026

Bullous Cutaneous Amyloidosis as the Initial Manifestation of Multiple Myeloma: A Case Report.

International journal of dermatology·2026

Understanding the Impact of Living With Psoriasis in the Philippines: A Global Psoriasis Atlas Online Survey.

International journal of dermatology·2026

The Role of Line-Field Confocal Optical Coherence Tomography in the Diagnosis of Melanoma and Melanocytic Lesions: A Systematic Review.

International journal of dermatology·2026

Persistent Truncal Eruption With Hematologic Disease.

International journal of dermatology·2026

Nevus Counts, Sun Exposure and Phenotypic Characteristics in Invasive Versus In Situ Non-Lentigo Maligna/Non-Acral Lentiginous Melanoma.

International journal of dermatology·2026

The Differential That Never Gets Generated.

International journal of dermatology·2026

Old Drugs, New Targets: Molecular Docking Insights into Repurposing Proton Pump Inhibitors for the TLR4/MD-2, NLRP3, and C5aR1 Axes in Autoimmune Liver Diseases.

Pharmaceuticals (Basel, Switzerland)·2026

Renoprotective vs. Antihypertensive Dosing of Renin-Angiotensin System Inhibitors in Chronic Kidney Disease: Analysis of Summary of Product Characteristics of Medicinal Products Authorized in Poland.

Journal of clinical medicine·2026

Comparative Veterinary Psychopharmacology in Dogs and Cats: Neurotransmitter Targets, Translational Boundaries, and Species-Specific Pharmacokinetics.

Animals : an open access journal from MDPI·2026

Clinical Development of Antibacterial Drugs: Recent Progress and Future Outlook.

Antibiotics (Basel, Switzerland)·2026

Discovery of Stereoselective Targeted Covalent Inhibitors of the RAB27-Effector Protein-Protein Interaction.

Journal of the American Chemical Society·2026

Recent Advances in the Enantiomeric Separation of Tropane Alkaloids by Liquid Chromatography: Analytical Strategies and Applications in Pharmaceutical, Biological, and Food Samples.

Toxins·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us